Clinical criteria updates for specialty pharmacy

The following clinical criteria document was endorsed at the April 19, 2022, Clinical Criteria meeting. Visit our website to access the clinical criteria information.

 

New clinical criteria effective September 1, 2022

The following clinical criteria is new:

• ING-CC-0200 Aduhelm (aducanumab-avwa)

 

CTBCBS-COMM-001678-22

NHBCBS-COMM-002013-22